Dravet | search
Click here to view Dravet news from 60+ newspapers.
Bookmark or Share- Stoke Therapeutics Announces Plans to Present New Data that Support ...Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged and refractory seizures, beginning within the first year of life. Dravet syndrome is difficult...
- Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy ...Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged and refractory seizures, beginning within the first year of life. Dravet syndrome is difficult...
- Stoke Therapeutics Reports Second Quarter Financial Results and ...Dravet syndrome is one of many diseases caused by a haploinsufficiency, in which a loss of ~50% of normal protein levels leads to disease.
- Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene ...Dravet syndrome is the most common developmental and epileptic encephalopathy and is characterized by a spectrum of clinical symptoms, including treatment-resistant seizures and...
- Stoke Therapeutics Highlights Strategic Priorities and Anticipated ...Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged and refractory seizures, beginning within the first year of life. Dravet syndrome is difficult...
More
